Executive summary of the American Radium Society® Appropriate Use Criteria for management of uterine carcinosarcoma

Mohamed A. Elshaikh, Ankit Modh, Anuja Jhingran, Matthew C. Biagioli, Robert L. Coleman, David K. Gaffney, Matthew M. Harkenrider, Karen Heskett, Shruti Jolly, Elizabeth Kidd, Larissa J. Lee, Linna Li, Lorraine Portelance, Tracy Sherertz, Aradhana M. Venkatessan, Andrew O. Wahl, Catheryn M. Yashar, William Small

Research output: Contribution to journalReview article

Abstract

Objective: Uterine carcinosarcomas (UCS) represent a rare but aggressive subset of endometrial cancers, comprising <5% of uterine malignancies. To date, limited prospective trials exist from which evidence-based management of this rare malignancy can be developed. Methods: The American Radium Society Appropriate Use Criteria presented in this manuscript are evidence-based guidelines developed by a multidisciplinary expert panel for management of women with UCS. An extensive analysis of current medical literature from peer-reviewed journals was performed. A well-established methodology (modified Delphi) was used to rate the appropriate use of imaging and treatment procedures for the management of UCS. These guidelines are intended for the use of all practitioners who desire information about the management of UCS. Results: The majority of patients with UCS will present with advanced extra uterine disease, with 10% presenting with metastatic disease. They have worse survival outcomes when compared to uterine high-grade endometrioid adenocarcinomas. The primary treatment for non-metastatic UCS is complete surgical staging with total hysterectomy, salpingo-oophorectomy and lymph node staging. Patients with UCS appear to benefit from adjuvant multimodality therapy to reduce the chance of tumor recurrence with the potential to improve overall survival. Conclusion: Women diagnosed with uterine UCS should undergo complete surgical staging. Adjuvant multimodality therapies should be considered in the treatment of both early- and advanced stage patients. Long-term surveillance is indicated as many of these women may recur. Prospective clinical studies of women with UCS are necessary for optimal management.

Original languageEnglish (US)
JournalGynecologic oncology
DOIs
StateAccepted/In press - 2020

Keywords

  • Carcinosarcoma
  • Chemotherapy
  • Hysterectomy
  • Radiotherapy
  • Uterine neoplasms

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Executive summary of the American Radium Society® Appropriate Use Criteria for management of uterine carcinosarcoma'. Together they form a unique fingerprint.

  • Cite this

    Elshaikh, M. A., Modh, A., Jhingran, A., Biagioli, M. C., Coleman, R. L., Gaffney, D. K., Harkenrider, M. M., Heskett, K., Jolly, S., Kidd, E., Lee, L. J., Li, L., Portelance, L., Sherertz, T., Venkatessan, A. M., Wahl, A. O., Yashar, C. M., & Small, W. (Accepted/In press). Executive summary of the American Radium Society® Appropriate Use Criteria for management of uterine carcinosarcoma. Gynecologic oncology. https://doi.org/10.1016/j.ygyno.2020.04.683